Liposomal 188 Rhenium Plus Macrophage Depletion Enhances Anti‐ PD ‐ L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer
Cancer Science · 2025
DOI: 10.1111/cas.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Shin-Yi Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Lung Neoplasms, Rhenium, Macrophages, Radioisotopes. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taitung MacKay Memorail Hospital, Mackay Memorial Hospital, China Medical University Hospital.
Abstract (Originalsprache)
Radionuclides such as Rhenium‐188 (Re188) hold promise for treating metastatic cancers due to their cytotoxic effects and potential to stimulate systemic anti‐tumor immunity. However, mononuclear phagocyte system‐mediated clearance of liposome encapsulated Re188 (Lipo‐Re188) limits its tumor delivery. This study aimed to enhance the therapeutic effect of Lipo‐Re188 against lung metastases through macrophage depletion and immune checkpoint blockade. A lung metastatic colon cancer model was established via intravenous injection of CT26‐luciferase cells and then treated with Lipo‐Re188 (11.1 MBq, 30% of MTD), liposomal clodronate (Lipo‐clod) for macrophage depletion, and/or anti‐PD‐L1 antibody. Tumor progression was monitored by bioluminescence imaging, and radionuclide biodistribution was assessed at 1, 24, and 48 h post‐injection. Flow cytometry was used to assess immune cell populations in the spleen and tumor microenvironment (TME). Cytokine levels were measured using a bead‐based multiplex assay and analyzed by flow cytometry. Macrophage depletion significantly enhanced tumor accumulation of Lipo‐Re188 while reducing hepatic uptake and prolonging survival. The combination of Lipo‐clod and Lipo‐Re188 promoted B cells, restored functional T cells, and suppressed MDSC in both spleen and TME. Notably, IL‐1α and GM‐CSF levels were significantly elevated in the combination group. Triple therapy with Lipo‐clod, Lipo‐Re188, and anti‐PD‐L1 provided the greatest survival benefit, highest intratumoral B cell accumulation, and lowest interstitial macrophage levels, with no significant biological toxicity. Our study reveals that triple therapy overcomes immunosuppressive feedback and promotes a tumor‐suppressive microenvironment. These findings support a rational combination strategy integrating radiopharmaceutical therapy with immune modulation for metastatic cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
- Department of Isotope Application Research, National Atomic Research Institute, Taoyuan, Taiwan.
- Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
- Department of Radiation Oncology, MacKay Memorial Hospital, Taipei, Taiwan.
ORCID-Profile: Shin-Yi Liu
Förderung
- Taitung MacKay Memorail Hospital
- Mackay Memorial Hospital
- China Medical University Hospital
- National Science and Technology Concil
Zitieren
APA
Liu, S. Y., Lin, L. T., Chang, C. H., & Chen, Y. J. (2025). Liposomal 188 Rhenium Plus Macrophage Depletion Enhances Anti‐ PD ‐ L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer. Cancer Science. https://doi.org/10.1111/cas.70206
Vancouver
Liu SY, Lin LT, Chang CH, Chen YJ. Liposomal 188 Rhenium Plus Macrophage Depletion Enhances Anti‐ PD ‐ L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer. Cancer Science. 2025. doi:10.1111/cas.70206
BibTeX
@article{Liu2025,
author = {Liu, Shin-Yi and Lin, Liang-Ting and Chang, Chih-Hsien and Chen, Yu-Jen},
title = {Liposomal 188 Rhenium Plus Macrophage Depletion Enhances Anti‐ PD ‐ L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70206}
}
EUVIMED